SGNCD352A

Biological Seattle Genetics, Inc.
Total Payments
$570,962
Transactions
76
Doctors
9
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2017 $570,962 76 9

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $552,779 52 96.8%
Honoraria $17,500 8 3.1%
Food and Beverage $683.76 16 0.1%

Payments by Type

Research
$552,779
52 transactions
General
$18,184
24 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
SGNCD352A0001 Seattle Genetics, Inc. $552,779 0

Top Doctors Receiving Payments for SGNCD352A

Doctor Specialty Location Total Records
Unknown Iowa City, IA $552,779 52
, M.D Hematology & Oncology Scottsdale, AZ $3,090 3
Gordon Cook Middletown, DE $2,590 3
, MD, PHD Hematology & Oncology Tampa, FL $2,090 3
, M.D Hematology & Oncology New York, NY $2,090 3
, MD Medical Oncology Philadelphia, PA $2,090 3
, MD Internal Medicine Duarte, CA $2,090 3
, MD Internal Medicine Little Rock, AR $2,028 2
, MD Medical Oncology Seattle, WA $2,028 2
, MD Hematology San Francisco, CA $89.80 2

About SGNCD352A

SGNCD352A is a biological associated with $570,962 in payments to 9 healthcare providers, recorded across 76 transactions in the CMS Open Payments database. The primary manufacturer is Seattle Genetics, Inc..

Payment data is available from 2017 to 2017. In 2017, $570,962 was paid across 76 transactions to 9 doctors.

The most common payment nature for SGNCD352A is "Unspecified" ($552,779, 96.8% of total).

SGNCD352A is associated with 1 research study, including "SGNCD352A0001" ($552,779).